CD19 and systemic lupus erythematosus: We conducted a scRNA-Seq–based analysis of PBMCs derived from a cohort of patients with SLE (Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.179433DS1) before and after a therapy with CD19 CAR T cells.